According to a study last year at Fox Chase Cancer Center, men whose prostate specific antigen (PSA) rise within 18 months of having primary radiotherapy are more likely to develop advanced prostate cancer and die of their disease. […]
A small study out of the Department of Urology, University of Rome, Rome, Italy has demonstrated that a salvage radical prostatectomy is a reasonable treatment option for men with locally recurrent prostate cancer after external beam radiotherapy failure. Despite the traditional belief that surgery can not follow failed radiation treatment, this argument against initial radiotherapy [...]
Investigators have reported, at the American Society for Therapeutic Radiation and Oncology (ASTRO) 50th Annual Meeting, that when radiation is added to anti-androgen therapy (ADT), survival rates are increased by 50% in men receiving only ADT. "This randomized trial is the first to show that men with locally advanced prostate cancer will survive substantially longer [...]
During radiation and chemotherapy, cancer patients including prostate cancer patients, should avoid the routine use of antioxidant supplements unless approved by their doctor. Supplements may reduce the anticancer benefits of therapy, researchers concluded in a commentary published online in the Journal of the National Cancer Institute. Radiation and Taxotere used for advanced prostate cancer therapy [...]